19 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-fda-approval-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-for-the-treatment-of-presbyopia-301959581.html
27 Jun 2023
// Kyle LaHucik ENDPTS
https://endpts.com/after-cutting-back-on-vuity-last-fall-abbvie-culls-a-second-gen-presbyopia-eye-drop/
07 Jun 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-pilocarpine-hydrochloride-ophthalmic-solution-38318.pdf
04 Jul 2022
// ASIAONE
https://www.asiaone.com/business/arctic-vision-announces-first-patient-enrolled-phase-iii-clinical-trial-arvn003-presbyopia
05 Apr 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/allergan-an-abbvie-company-announces-positive-topline-phase-3-results-evaluating-investigational-twice-daily-administration-of-vuity-pilocarpine-hci-ophthalmic-solution-1-25-in-adults-with-age-related-blurry-near-vision-pre-301517329.html
LOOKING FOR A SUPPLIER?